SCANCELL HOLDINGS PLC
Company number 06564638 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Overview
- Company type
- Public Limited Company
- Incorporated
- 2008-04-14
- Registered office
- Bellhouse Building Sanders Road, Oxford Science Park, Oxford, England, OX4 4GD
- Postcode
- OX4 4GD
- Capital
- 1 GBP
- Accounts category
- Group
Accounts
- Last made up to
- 2025-04-30
- Next due by
- 2026-10-31
- Financial year end
- 30 April
Confirmation statement
- Last statement dated
- 2026-04-14
- Next due by
- 2027-04-28
Nature of business (SIC)
- 72190 Other research and experimental development on natural sciences and engineering
- 86900 Other human health activities
Officers 10 current · 18 resigned
Alexander HAYWARD
Secretary
Phillip John, Dr L’HUILLIER
Director
Jean-Michel, Dr COSSERY
Director
Susan Elizabeth CLEMENT DAVIES
Director
Group structure 2 subsidiaries
From persons-with-significant-control filings on the public register.
Contact details
- Website
- scancell.co.uk
Scancell is a clinical stage immunotherapy biotech developing treatments for significant unmet needs in cancer.
Previous registered addresses 3
| Address | Changed on |
|---|---|
| EVERSHEDS HOUSE 70 GREAT BRIDGEWATER STREET, MANCHESTER, M1 5ES | 2017-04-12 |
| 2 MORE LONDON RIVERSIDE, LONDON, SE1 2AP | 2014-11-06 |
| FIFTH FLOOR CARMELITE, 50 VICTORIA EMBANKMENT, LONDON, EC4Y 0LS | 2012-01-11 |
The class of 2008
24%
of the 507 companies in this sector incorporated in 2008 are still active today; 74% have since been dissolved.
A fact about the year, not a forecast for this company.